NOVA1 Antikörper (AA 411-510) (Alexa Fluor 594)
-
- Target Alle NOVA1 Antikörper anzeigen
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
-
Bindungsspezifität
- AA 411-510
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser NOVA1 Antikörper ist konjugiert mit Alexa Fluor 594
-
Applikation
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Human, Maus, Ratte
- Homologie
- Cow,Chicken
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human NOVA1
- Isotyp
- IgG
- Top Product
- Discover our top product NOVA1 Primärantikörper
-
-
- Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
- Andere Bezeichnung
- Nova1 (NOVA1 Produkte)
- Synonyme
- Nova-1 antikoerper, NOVA1 antikoerper, si:ch211-222c22.9 antikoerper, 9430099M15Rik antikoerper, G630039L02 antikoerper, NOVA alternative splicing regulator 1 antikoerper, neuro-oncological ventral antigen 1 L homeolog antikoerper, neuro-oncological ventral antigen 1 antikoerper, RNA-binding protein Nova-1 antikoerper, lipid A export ATP-binding/permease protein antikoerper, NOVA1 antikoerper, Nova1 antikoerper, nova1.L antikoerper, nova1 antikoerper, LOC790874 antikoerper, novA1 antikoerper
- Hintergrund
-
Synonyms: Neuro oncological ventral antigen 1, Neuro-oncological ventral antigen 1, NOVA 1, Nova-1, Nova1, NOVA1_HUMAN, Onconeural ventral antigen 1, Paraneoplastic Ri antigen, RNA binding protein Nova 1, RNA-binding protein Nova-1, Ventral neuron specic protein 1, Ventral neuron-specic protein 1.
Background: Nova-1 and Nova-2 are members of a superfamily of protein regulators of RNA metabolism in neurons. Both are nuclear RNA binding proteins with K homology motifs, conserved protein sequences which bind to RNA (1,2). Nova proteins, normally sequestered in the central nervous system, are expressed by systemic tumors in patients with the autoimmune disorder paraneoplastic opsoclonus-myoclonus ataxia (POMA) (3,4). Nova-1 is expressed in the hindbrain and ventral spinal cord and Nova-2 is expressed in the neocortex and hippocampus (4). Nova-1 is necessary for regulating neuron-specific alternative splicing of the glycine receptor Alpha2 pre-mRNA (5).
- UniProt
- P51513
-